Clinical Trials Browser

Phase 2 × Waldenstrom Macroglobulinemia × pembrolizumab × Clear all

NCT03630042 2024-11-07

PembroWM

Phase 2 Completed

17 enrolled 7 charts

Waldenstrom Macroglobulinemia, Recurrence

NCT02332980 2024-01-03

Pembrolizumab Alone or With Idelalisib or Ibrutinib in Treating Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell Non-Hodgkin Lymphomas

Phase 2 Completed

65 enrolled 21 charts

LymphoidOther hematologic neoplasm

Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Leukemia, Lymphocytic, Chronic, B-Cell, Lymphoma, B-Cell, Lymphoma, B-Cell, Marginal Zone